Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety

Gammoh,Omar; Mayyas,Fadia; Darwish Elhajji,Feras

doi:10.3892/br.2017.901

Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety

Authors:
- Omar Gammoh
- Fadia Mayyas
- Feras Darwish Elhajji
View Affiliations

Affiliations: Department of Pharmacy, American University of Madaba, Amman 11821, Jordan, Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan
Published online on: May 3, 2017 https://doi.org/10.3892/br.2017.901
Pages: 675-680

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is a crosstalk between mood disorders and oxidative stress. Chlorpheniramine (CPA), a first generation antihistamine, is hypothesized to have an anxiolytic role at high doses; however, its antidepressant and antioxidant roles have not previously been investigated. The aim of the current study was to evaluate the antidepressant and anxiolytic effects of CPA treatment in association with nitric oxide (NO) and super oxide dismutase (SOD) activity in a mouse model of anxiety. BALB/c mice were divided into unstressed (naïve), control, and CPA‑ (0.5 mg/kg) and escitalopram‑ (ESC; 10 mg/kg) treated groups for 3 weeks. Subsequently, they were immobilized for 6 h and subjected to behavioural paradigms as follows: The open field test, the elevated plus maze (EPM) and the forced swim test to investigate motor function, anxiety and depression, respectively. The mice were sacrificed and serum was obtained to detect NO and SOD activity. Compared with the control group, the CPA‑treated group demonstrated an antidepressant effect similar to that of the ESC‑treated group. In addition, CPA prevented stress‑induced NO without affecting SOD activity. CPA did not improve anxiety‑like behaviour in the EPM, nor did it improve stress-induced locomotion and rearing, as demonstrated by the OFT. Thus, to the best of our knowledge, this is the first study to evaluate the antidepressant role of CPA in association with NO metabolism. However, further studies are required to elucidate the underlying mechanism.

View Figures

View References

1	Hawgood J and De Leo D: Anxiety disorders and suicidal behaviour: An update. Curr Opin Psychiatry. 21:51–64. 2008. View Article : Google Scholar : PubMed/NCBI
2	Brown RE, Stevens DR and Haas HL: The physiology of brain histamine. Prog Neurobiol. 63:637–672. 2001. View Article : Google Scholar : PubMed/NCBI
3	Kumar KV, Krishna DR and Palit G: Histaminergic H1 receptors mediate L-histidine-induced anxiety in elevated plus-maze test in mice. Behav Pharmacol. 18:213–217. 2007. View Article : Google Scholar : PubMed/NCBI
4	Zarrindast MR, Nasehi M, Piri M and Bina P: Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice. Pharmacol Biochem Behav. 94:387–396. 2010. View Article : Google Scholar : PubMed/NCBI
5	Rizk A, Curley J, Robertson J and Raber J: Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci. 19:1992–1996. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hellbom E and Humble M: Panic disorder treated with the antihistamine chlorpheniramine. Ann Allergy Asthma Immunol. 90:361362, author reply 361–362. 2003. View Article : Google Scholar : PubMed/NCBI
7	Tatsumi M, Groshan K, Blakely RD and Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 40:249–258. 1997. View Article : Google Scholar
8	Hirano S, Miyata S, Onodera K and Kamei J: Effects of histamine H(1) receptor antagonists on depressive-like behavior in diabetic mice. Pharmacol Biochem Behav. 83:214–220. 2006. View Article : Google Scholar : PubMed/NCBI
9	Onodera K, Sakurai E and Niwa H: Effect of chlorpheniramine on muricide induced by thiamine deficiency: Pharmacokinetic and behavioral studies. Agents Actions. 20:229–232. 1987. View Article : Google Scholar : PubMed/NCBI
10	Serafim KR, Kishi MS, Canto-de-Souza A and Mattioli R: H1 but not H2 histamine antagonist receptors mediate anxiety-related behaviors and emotional memory deficit in mice subjected to elevated plus-maze testing. Braz J Med Biol Res. 46:440–446. 2013. View Article : Google Scholar : PubMed/NCBI
11	Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K and Gałecka E: Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol. 24:277–286. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wei YC, Zhou FL, He DL, Bai JR, Hui LY, Wang XY and Nan KJ: The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. J Psychosom Res. 66:259–266. 2009. View Article : Google Scholar : PubMed/NCBI
13	Chen HJC, Spiers JG, Sernia C and Lavidis NA: Response of the nitrergic system to activation of the neuroendocrine stress axis. Front Neurosci. 9:32015. View Article : Google Scholar : PubMed/NCBI
14	Gammoh OS, Al-Smadi A, Al-Awaida W, Badr MM and Qinna NA: Increased salivary nitric oxide and G6PD activity in refugees with anxiety and stress. Stress Health. 32:435–440. 2016. View Article : Google Scholar : PubMed/NCBI
15	Jin L, Qin L, Xia D, Liu X, Fan Z, Zhang C, Gu L, He J, Ambudkar IS, Deng D and Wang S: Active secretion and protective effect of salivary nitrate against stress in human volunteers and rats. Free Radic Biol Med. 57:61–67. 2013. View Article : Google Scholar : PubMed/NCBI
16	Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, Boscá L and Leza JC: Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem. 74:785–791. 2000. View Article : Google Scholar : PubMed/NCBI
17	Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C and Bouzinova EV: Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. AJP Regulatory Integrative and Comparative Physiology. 15:R814–R823. 2015. View Article : Google Scholar
18	Blokhina O, Virolainen E and Fagerstedt KV: Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot. 91:179–194. 2003. View Article : Google Scholar : PubMed/NCBI
19	Shimazoe T, Shibata S and Ueki S: A new forced swimming test for the evaluation of antidepressants in rats by recording vibration of a water tank. J Pharmacobiodyn. 10:639–643. 1987. View Article : Google Scholar : PubMed/NCBI
20	Roy V, Belzung C, Delarue C and Chapillon P: Environmental enrichment in BALB/c mice: Effects in classical tests of anxiety and exposure to a predatory odor. Physiol Behav. 74:313–320. 2001. View Article : Google Scholar : PubMed/NCBI
21	Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C and Bouzinova EV: Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. Am J Physiol Regul Integr Comp Physiol. 309:R814–R823. 2015. View Article : Google Scholar : PubMed/NCBI
22	Machawal L and Kumar A: Possible involvement of nitric oxide mechanism in the neuroprotective effect of rutin against immobilization stress induced anxiety like behaviour, oxidative damage in mice. Pharmacol Rep. 66:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
23	Gioiosa L, Iannitelli A and Aloe L: Stress, anxiety and schizophrenia and neurotrophic factors: The pioneer studies with nerve growth factor. Riv Psichiatr. 44:88–94. 2009.PubMed/NCBI
24	Porsolt RD, Bertin A and Jalfre M: ‘Behavioural despair’ in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol. 51:291–294. 1978. View Article : Google Scholar : PubMed/NCBI
25	Privou C, Knoche A, Hasenöhrl RU and Huston JP: The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology. 37:1019–1032. 1998. View Article : Google Scholar : PubMed/NCBI
26	Dishman RK, Armstrong RB, Delp MD, Graham RE and Dunn AL: Open-field behavior is not related to treadmill performance in exercising rats. Physiol Behav. 43:541–546. 1988. View Article : Google Scholar : PubMed/NCBI
27	Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS and Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 126:131–138. 1982. View Article : Google Scholar : PubMed/NCBI
28	Omori A, Yoshimura Y, Deyama Y and Suzuki K: Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells. Biomed Rep. 3:483–490. 2015.PubMed/NCBI
29	Domino EF: History of modern psychopharmacology: A personal view with an emphasis on antidepressants. Psychosom Med. 61:591–598. 1999. View Article : Google Scholar : PubMed/NCBI
30	Page ME, Detke MJ, Dalvi A, Kirby LG and Lucki I: Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl). 147:162–167. 1999. View Article : Google Scholar : PubMed/NCBI
31	Kala M and Nivsarkar M: Role of cortisol and superoxide dismutase in psychological stress induced anovulation. Gen Comp Endocrinol. 225:117–124. 2016. View Article : Google Scholar : PubMed/NCBI
32	Miyata S, Hirano S, Ohsawa M and Kamei J: Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice. Psychopharmacol. 213:441–452. 2011. View Article : Google Scholar
33	Biala G, Pekala K, Boguszewska-Czubara A, Michalak A, Kruk-Slomka M and Budzynska B: Behavioral and biochemical interaction between nicotine and chronic unpredictable mild stress in mice. Mol Neurobiol. 54:904–921. 2017. View Article : Google Scholar : PubMed/NCBI
34	Schmidt AJ, Heiser P, Hemmeter UM, Krieg JC and Vedder H: Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. Prog Neuropsychopharmacol Biol Psychiatry. 32:1567–1573. 2008. View Article : Google Scholar : PubMed/NCBI